128 related articles for article (PubMed ID: 37531901)
21. Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-
Liang E; Liu X; Du Z; Yang R; Zhao Y
Oxid Med Cell Longev; 2018; 2018():9086747. PubMed ID: 30046380
[TBL] [Abstract][Full Text] [Related]
22. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
[TBL] [Abstract][Full Text] [Related]
23. β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo.
Wang H; Ma Y
Cancer Cell Int; 2022 Jul; 22(1):244. PubMed ID: 35909161
[TBL] [Abstract][Full Text] [Related]
24. Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models.
Fu Z; Mui D; Zhu H; Zhang Y
Aging (Albany NY); 2020 May; 12(9):8640-8651. PubMed ID: 32392536
[TBL] [Abstract][Full Text] [Related]
25. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
26. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
27. JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53.
Fang T; Wang J; Sun S; Deng X; Xue M; Han F; Sun B; Chen L
Phytomedicine; 2024 Jul; 130():155659. PubMed ID: 38759318
[TBL] [Abstract][Full Text] [Related]
28. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways.
Tang SG; Liu XY; Ye JM; Hu TT; Yang YY; Han T; Tan W
J Endocrinol; 2018 Jul; 238(1):47-60. PubMed ID: 29720537
[TBL] [Abstract][Full Text] [Related]
29. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
30. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells
Zhang T; Ouyang H; Mei X; Lu B; Yu Z; Chen K; Wang Z; Ji L
FASEB J; 2019 Nov; 33(11):11776-11790. PubMed ID: 31365278
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB.
Wang Y; Sun W; Du B; Miao X; Bai Y; Xin Y; Tan Y; Cui W; Liu B; Cui T; Epstein PN; Fu Y; Cai L
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(4):H567-78. PubMed ID: 23220333
[TBL] [Abstract][Full Text] [Related]
32. Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy.
Zuo GF; Ren XM; Ge Q; Luo J; Ye P; Wang F; Wu W; Chao YL; Gu Y; Gao XF; Ge Z; Gao HB; Hu ZY; Zhang JJ; Chen SL
J Mol Cell Cardiol; 2019 May; 130():170-183. PubMed ID: 30998977
[TBL] [Abstract][Full Text] [Related]
33. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation.
Hao J; Zhou J; Hu S; Zhang P; Wu H; Yang J; Zhao B; Liu H; Lin H; Chi J; Lou D
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C331-C347. PubMed ID: 38047307
[TBL] [Abstract][Full Text] [Related]
34. Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathway.
Han X; Zhou W; Zhang J; Tu Y; Wei J; Zheng R; Zhu J; Xu D; Ying H; Wu G; Shi Q; Liang G
Int Immunopharmacol; 2023 Nov; 124(Pt B):110984. PubMed ID: 37757635
[TBL] [Abstract][Full Text] [Related]
35. Sclareol ameliorates hyperglycemia-induced renal injury through inhibiting the MAPK/NF-κB signaling pathway.
Han X; Zhang J; Zhou L; Wei J; Tu Y; Shi Q; Zhang Y; Ren J; Wang Y; Ying H; Liang G
Phytother Res; 2022 Jun; 36(6):2511-2523. PubMed ID: 35434887
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
[TBL] [Abstract][Full Text] [Related]
37. CAPE-pNO
Fan L; Xiao Q; Zhang L; Wang X; Huang Q; Li S; Zhao X; Li Z
Biomed Pharmacother; 2018 Dec; 108():1640-1650. PubMed ID: 30372866
[TBL] [Abstract][Full Text] [Related]
38. Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
Li G; Yang L; Feng L; Yang J; Li Y; An J; Li D; Xu Y; Gao Y; Li J; Liu J; Yang L; Qi Z
Mol Nutr Food Res; 2020 Sep; 64(18):e2000231. PubMed ID: 32729956
[TBL] [Abstract][Full Text] [Related]
39. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
40. Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy.
Suzuki H; Kayama Y; Sakamoto M; Iuchi H; Shimizu I; Yoshino T; Katoh D; Nagoshi T; Tojo K; Minamino T; Yoshimura M; Utsunomiya K
Diabetes; 2015 Feb; 64(2):618-30. PubMed ID: 25187369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
